Post-chemotherapy microscopic residual prostate rhabdomyosarcoma: long-term conservative follow-up

In spite of advances in the treatment of childhood bladder and prostate rhabdomyosarcoma (RMS), the ability to detect minimal residual disease correlates imperfectly with the ultimate outcome. We report the long-term follow-up of a child with microscopic residual RMS after chemotherapy. The correct...

Full description

Saved in:
Bibliographic Details
Published inPediatric surgery international Vol. 18; no. 1; pp. 68 - 69
Main Authors CHERTIN, Boris, REINUS, Constantin, KOULIKOV, Dmitry, ROSENMANN, Eliezer, FARKAS, Amicur
Format Journal Article
LanguageEnglish
Published Heidelberg Springer 2002
Berlin Springer Nature B.V
Subjects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Humans
Infant
Male
Medical sciences
Neoplasm, Residual
Prostatic Neoplasms - congenital
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Rhabdomyosarcoma - congenital
Rhabdomyosarcoma - drug therapy
Rhabdomyosarcoma - pathology
Urinary Bladder Neoplasms - congenital
Urinary Bladder Neoplasms - drug therapy
Urinary Bladder Neoplasms - pathology
Online AccessGet full text

Cover

More Information
Summary:In spite of advances in the treatment of childhood bladder and prostate rhabdomyosarcoma (RMS), the ability to detect minimal residual disease correlates imperfectly with the ultimate outcome. We report the long-term follow-up of a child with microscopic residual RMS after chemotherapy. The correct interpretation of the histologic findings spared the child unnecessary additional therapy and raises enigmatic questions about the biology of minimal residual disease.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0179-0358
1437-9813
DOI:10.1007/s003830200017